Market Place
Sourcing Support
Amphivena Presents Translational Data Highlighting the Cytokine Profile
13 Apr 2021 //
BUSINESSWIRE
Amphivena Presents Translational Data Highlighting the Cytokine Profile
13 Apr 2021 //
BUSIESSWIRE
Amphivena Announces First Patient Dosed in the Phase 1 Dose of AMV564
16 Dec 2020 //
BIOSPACE
Amphivena Presents Clinical Update and Translational Data of AMV564
09 Nov 2020 //
PRNEWSWIRE
Amphivena Presents Translational Data for its Lead Clinical Candidate, AMV564
23 Jun 2020 //
PRNEWSWIRE
Amphivena Presents Data from First-in-Human Study of AMV564 in Solid Tumor
29 May 2020 //
PRNEWSWIRE
Amphivena Therapeutics to Present at the Jefferies Virtual Healthcare Conference
29 May 2020 //
PRNEWSWIRE
Amphista Therapeutics Raises $7.5m Series A Round
07 Apr 2020 //
PR NEWSWIRE
Amphista Therapeutics Raises $7.5m Series A Round to Advance Targeted
06 Apr 2020 //
PR NEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.